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Serum-free cultured neuroblastoma cells (clone NIE-115) have been shown to absorb emulsified gluco- 
sylceramide, glucosylceramide glucosidase, an activator protein for the enzyme, and phosphatidylserine from 
a synthetic medium. Uptake of the enzyme was augmented by phosphatidylserine, and vice versa. Uptake of 
the enzyme-lipid complex was further augmented by the activator protein. It appears likely that the activator 
forms a complex only with the enzyme-lipid complex, not with the individual components. Two uptake 
mechanisms for the enzyme seem to be involved, one of which (the complex with activator proteins and 
acidic lipid) is sensitive to mannosyl phosphate groups. Hydrolysis of absorbed glucosylceramide was slow 
unless the medium was supplemented with the acidic phospholipid or glucosidase. The most rapid disap- 
pearance of stored glycolipid took place when the ternary mixture was added to the cell medium, 
enzyme + activator protein + phosphatidylserine. These findings may be relevant to enzyme replacement 
therapy for Gaucher disease. 
Introduction 
Some genetic disorders characterized by low-ef- 
ficiency enzymes can, in theory, be treated by 
injecting the normal enzyme. One must hope that 
most of the normal enzyme molecules will reach 
the required sites of action and survive long enough 
to eliminate accumulated substrate. The enzyme 
can be injected intravenously in the free form, as a 
complex with an antibody, or as an inclusion of a 
liposome or red cell ghost. Alternatively, it can be 
modified chemically to resist proteolytic degrada- 
tion or enable it to enter cells via specific recep- 
tors. We describe a new system in which the 
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enzyme is bound noncovalently to its natural 
activators and then effectively taken up by cells in 
vitro. 
The model system was developed with cultured 
neuroblastoma cells of murine origin (clone NlE- 
115) grown under serum-free conditions. The en- 
zyme studied was glucosylceramide (GlcCer) 
/3-glucosidase (EC 3.2.1.45). This is the enzyme 
which occurs in defective form in individuals with 
Gaucher disease. A striking result of the genetic 
defect is a large accumulation of the substrate, a 
glucosphingolipid which is a precursor of several 
nonionic glycolipids and most of the gangliosides. 
Another striking aspect of the disorder is an accu- 
mulation of a family of activator proteins, called 
cohydrolase here. The activator proteins stimulate 
not only the glucosidase but also sphingomyelinase 
and galactosylceramide /3-galactosidase [l-3]. 
Cohydrolase forms a complex with glucosidase, 
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apparently in conjunction with an acidic phos- 
pholipid such as phosphatidylserine [4,5]. The 
complex exhibits a lowered K, for its substrate as 
well as higher activity. Additional evidence for the 
formation of a ternary complex has come from 
density gradient centrifugation [6] and tests with 
an inactivator of the enzyme [7]. The acidic phos- 
pholipid itself also acts as a stimulator of the 
enzyme. Immobilized cohydrolase, attached to 
Sepharose 4B, binds the crude enzyme and affords 
significant purification [4]. This paper describes 
cellular uptake from the culture medium of the 
various substances involved. 
Materials and Methods 
Chemicals 
Cohydrolase was isolated from bovine spleen 
[8] and stored at 4°C in buffer A (5 mM phos- 
phate (pH 7)/40 mM NaCl) containing 0.02% 
NaN,. It was separated into two fractions, one 
that does not adhere to concanavalin A-Seph- 
arose, and one that does bind and is eluted with 
0.5 M NaCl and 0.5 M methyl a-mannoside in 5 
mM (pH 7) phosphate [9]. The latter form, after 
dialysis against buffer A, was used in most of 
these experiments. 
Bovine brain phosphatidylserine (PS) was from 
Avanti Polar Lipids and phosphatidyl[U-‘4C]- 
serine (dioleoyl) was from Amersham. A solution 
containing the former or a mixture of both (26 
cpm/pg) was evaporated to dryness, sonicated in 
a cold bath with culture medium, and sterilized by 
filtration (0.2 pm Acrodisc assembly, Gelman Sci- 
entific). Sodium taurocholate was from 
Calbiochem Behring. Mannose 6-phosphate, 
methyl cy-mannoside, calf thymus DNA, glucose 
6-phosphate, mannose, and concanavalin A-Seph- 
arose CL4B were from Sigma. A pentamannoside 
monophosphate was prepared from Halo- 
bacterium ho&ii [lo]. 
GlcCer (glucocerebroside), isolated from a 
Gaucher spleen, was dissolved in chloroform/ 
methanol with half its weight of Myrj 52 (a solid 
polyoxyethylene stearate with a hydrophile-lipo- 
phile balance rating of 16.9 from ICI Americas 
Inc., Wilmington, DE). The solution was 
evaporated to dryness and converted to a milky 
emulsion with 0.9% NaCl or culture medium in an 
ultrasonic bath and sterilized by filtration just 
before addition to the medium. Some of the GlcCer 
was converted to [6- 3 Hlglucosylceramide [ 111. 
Glucocerebrosidase was purified and delipid- 
ated from fresh human placenta by cholate extrac- 
tion, ammonium sulfate precipitation, acid pre- 
cipitation, butanol extraction, and affinity chro- 
matography [12]. The enzyme was dialyzed against 
culture medium and concentrated under vacuum 
in the dialyzer just before use. 
Cells 
Murine neuroblastoma cells (clone NlE-115) 
passage 10-14, were grown in Dulbecco’s mod- 
ified Eagle’s medium (GIBCO) supplemented (in 
amounts per liter) with 5 mg of insulin, 20 nmol 
progesterone, 0.1 mm01 putrescine, 30 nmol 
selenite, 100 mg of transferrin, 1.4 mg of vitamin 
B-12, 7 pg of biotin, and 0.2 mg of thioctic acid 
[13]. Subculture was achieved by inoculating 4.10’ 
cells into 75 cm2 plastic tissue culture flasks con- 
taining 20 ml of medium supplemented with 10% 
fetal bovine serum (GIBCO) without antibiotics. 
After 24 h of culture at 37 o C in 10% CO,/ humid- 
ified air, the medium was removed and replaced 
with 20 ml of serum-free medium. The cells were 
fed on days 4 and 6, and every day thereafter, by 
adding 10 ml of fresh medium and removing 10 
ml of medium. 
After 6 days of culture in serum-free medium, 
the medium was removed and replaced with 20 ml 
of serum-free medium containing a small volume 
of test substance(s). Control and experimental 
flasks were incubated at 37“C in duplicate. At the 
end of the test incubation, the medium was re- 
moved and the cells were incubated for 5 min in 
Puck’s Dl solution without trypsin [14]. They 
were then removed from the flasks, pooled, iso- 
lated by centrifugation, suspended in phosphate- 
buffered saline (pH 7), sonicated on ice, and as- 
sayed. 
Assays 
Cohydrolase concentrations were measured with 
an immunoassay [15] with two portions of a cell 
extract, each purified with a size exclusion column 
and analyzed in duplicate. The uptake of 
cohydrolase was calculated from the formula, 
B uptake = 100. ( Cexpenmental - C,n,,,,) ‘wt. protein/W. CH 
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where C is the concentration of cohydrolase in the 
control or experimental (cohydrolase-treated) cells, 
wt. protein is the weight of protein in the 
cohydrolase-treated cells, and wt. cohydrolase is 
the weight of cohydrolase added to the flasks. A 
similar calculation was used for the enzyme, with 
activity units instead of weights. This formula, 
which assumes that the endogenous level within 
the cells is unchanged by the uptake, corrects for 
the small differences in protein content between 
the different pooled groups. 
Glucosidase activity was determined by a 30- 
min incubation in acetate pH 5.4 and Triton X-100, 
0.5 mg/ml, with either methylumbelliferyl-2-&D- 
glucopyranoside or with [ 3 H]GlcCer as substrate. 
In the latter case, sodium taurocholate (5 mg/ml) 
was included [16]. One cerebroside or methyl- 
umbelliferyl-2-P-D-glucopyranoside unit of activ- 
ity is the amount of enzyme which hydrolyzes 1 
nmol/h of substrate. Assays were run with two 
different amounts of sample to ensure the absence 
of interfering materials; the observed specific ac- 
tivities generally agreed within 4%. The endogen- 
ous cohydrolase in the cells was too low to affect 
the measured glucosidase activities when methyl- 
umbelliferyl-2-/I-D-glucopyranoside was the sub- 
strate. Tests of the enzyme assay system with 
labeled GlcCer as the substrate showed that the 
presence of 4 pg PS in the 0.2 ml of incubation 
medium or 50 pg of cohydrolase with the phos- 
pholipid did not significantly change the observed 
activities. 
Radioactivity was determined by scintillation 
counting of the wet cells or lipid extract in a 
water-miscible system. Analysis of the cell lipids 
was carried out by extracting cells with hexane/ 
isopropyl alcohol 3 : 2 and chromatographing the 
lipids on silica gel-coated TLC plates (E. Merck, 
No. 5763-7) with chloroform/ methanol/ water 
24: 7 : 1. The water contained 1 M NH,OH and 
KCl, 2.5 mg/ml. 
Protein was determined by a calorimetric pre- 
cipitation-Folin reaction with bovine serum al- 
bumin as standard [17] and DNA was determined 
by the diaminobenzoic acid fluorescence method 
1181. 
Results 
Occurrence of cohydrolase and glucosidase in the 
ceils 
The NlE-115 cells, cultured in normal (10% 
fetal bovine serum) and in serum-free media, were 
found to contain cohydrolase (Table I), at a con- 
centration similar to that found in mouse brain 
[15]. Its concentration, relative to total cell pro- 
tein, did not change appreciably with time over 
the 7-day period studied. In contrast, the specific 
activity of glucosidase rose greatly. The two cul- 
ture conditions employed yielded similar values 
and all later experiments were done in serum-free 
media with cells that had been grown in serum-free 
medium for 6 days. 
Uptake of cohydrolase by cells 
The cells were found to absorb cohydrolase 
from the medium, the amount increasing with 
time (Fig. 1). In this study, the activator prepara- 
tion included the two types of protein - the kind 
which binds to concanavalin A-Sepharose and the 
kind which does not. The former type was 56% of 
the total. Calculating from the individual control 
flasks for each time point, one sees that the cells 
took up 9, 13, 14, and 19% of the added factor by 
the end of 1, 2, 4, and 6 h, respectively. The 
reproducibility of the system is illustrated by the 
horizontal nature of the lower curve (control cells) 
and by the duplicate sample values in the figure. 
Comparison of the two kinds of cohydrolase in 
a 6-h incubation showed that the concanavalin 
binding form was taken up more efficiently: 36% 
vs. 18% (Table II). This form was used in all the 
later experiments. Significantly, we found that 
cohydrolase was not removed from the cells on 
washing, although some loosely bound protein 
was lost. This shows that the absorbed cohydro- 
lase was firmly bound to the surface or internal- 
ized. In addition, the data show that endogenous 
cohydrolase did not leak out of the cells into the 
medium. The concentration of cohydrolase in the 
control cells, 1.72 ng/ml protein, was similar to 
the values found in other experiments (Table I 
and Fig. 1). 
Since cohydrolase is a glycoprotein, we were 
interested in determining whether the uptake phe- 
nomenon involved a mannosyl phosphate receptor 
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TABLE I 
GROWTH PROPERTIES OF NIE-115 CELLS WITH RESPECT TO TOTAL PROTEIN. GLUCOSYLCERAMIDE GLUCO- 
SIDASE, AND COHYDROLASE CONTENT 
The protein values are derived from two culture dishes, each containing 20 ml medium, and the other values are based on the total 
protein values. The glucosidase activities are in methylumbelliferyl-2-/3-o-glucopyranoside units. Each measurement shown is a mean 
of duplicate assays. 
Age Protein Glucosidase Cohydrolase Ratio 
(days) (mg) 
+ serum - serum 
activity 
(a) (nmol/h per mg) 
+ serum - serum 
concentration (a)/(b) 
(b) (ng/mg) 
+ serum -serum + serum - serum 
3 3.8 5.0 10 7 1.7 1.5 6 4 
4 5.7 5.9 15 14 1.6 1.6 9 9 
6 16 10.9 23 I6 1.5 1.5 15 11 
7 24 25 25 22 1.8 1.6 14 13 
8 22 18 32 29 1.6 1.5 20 19 
10 28 24 38 33 1.7 1.5 22 21 
on the cell surface. When cells were incubated for 
6 h with 2 mM mannose 6-phosphate, almost 
complete blockage of cohydrolase uptake was ob- 
tained (upper part of Table III). Mannose phos- 
phate alone (line 2) had little or no effect on the 
endogenous cell level of cohydrolase. The uptake 
of cohydrolase from the normal medium was 49%, 
based on the average of the two control groups 
(lines 1 and 2). This was reduced by 86% when 
mannose phosphate was included in the incuba- 
tion. 
Another experiment (lower part of Table III) 
showed that other carbohydrates also interfered 
with cohydrolase uptake. A pentamannoside 
TABLE II 
UPTAKE OF TWO COHYDROLASE (CH) FORMS BY INCUBATED CELLS 
Conditions as in Table I. Two flasks were incubated under each condition for 6 h and the pooled media were saved for analysis. The 
cells from each dish were washed for 5 min at 37°C with 5 ml of Puck’s Dl solution without trypsin, pooled, then sonicated in 5 mM 
phosphate (pH 7) containing 1 M NaCl and analyzed. The cells of group CH.ConA - were incubated with 13.5 ng of non-binding 
cohydrolase in two flasks; group CH.ConA+, with 15 ng of concanavalin A-binding cohydrolase. The degree of variability in the 
cohydrolase assays is indicated in the duplicate values shown for cohydrolase in the cells. 
Cells Fraction Protein Cohydrolase 
analyzed content content 
(mg) (ng) 
Control medium 12.0 0.0 
wash 1.15 0.0 
cells 7.4 12.9, 12.6 
CH.ConA + medium 12.0 7.08 
wash 1.45 0.0 
cells 7.4 17.9, 18.2 
CH.ConA - medium 13.5 7.68 
wash 1.45 0.0 
cells 7.5 15.2, 14.9 
- 
* These values have been corrected for the endogenous level of cohydrolase. 
Cohydrolase 
present 















INCUBATION TIME (hours1 
Fig. 1. Uptake of cohydrolase (CH) by neuroblastoma cells as 
a function of time. Each flask contained 7.5 ng of mixed types 
of cohydrolase in 20 ml of medium and the cells from two 
flasks were pooled for assay. The lower curve shows the 
cohydrolase contents of control cells incubated without added 
cohydrolase. 
monophosphate was quite effective, reducing co- 
hydrolase uptake by 67% at a concentration of 
only 300 ng/ml. Mannose itself (10 mM) reduced 
cohydrolase uptake by 63% and 2 mM glucose 
6-phosphate also showed some blocking activity: 
33%. 
Effect of glucosidase on cohydrolase uptake 
Uptake of cohydrolase was not appreciably 
improved by adding glucosidase to the medium 
(Table IV). In this study, 7.5 ng of cohydrolase 
were added to the 20 ml of medium in each dish, 
giving an uptake of 49% in 6 h. Including gluco- 
sidase (495 methylumbelliferyl-2-b-D-glucopyran- 
oside units/flask) brought the uptake of cohydro- 
lase to 54%. The enzyme uptake, 24%, was the 
same with or without cohydrolase. From these 
findings, it would appear that the two proteins do 
not interact in the absence of lipids. It may be 
noted that the amount of enzyme taken up was far 
greater than the endogenous level. The recovery of 
added enzyme in cells and medium was 74% with 
or without added cohydrolase. 
In a similar experiment, with PS in the medium 
of all flasks but two (20 pg/ml), cohydrolase 
uptake was 45% without enzyme and 40% with 
enzyme (Table V). However, the glucosidase up- 
take was definitely improved by cohydrolase, in- 
creasing from 31% without to 48% with cohydro- 
lase. The latter observation can be interpreted to 
mean that cohydrolase does combine with the 
enzyme if PS is present, and that this complex is 
absorbed more efficiently than free enzyme. The 
TABLE III 
EFFECT OF CARBOHYDRATES ON UPTAKE OF COHYDROLASE (CH) 
Conditions as in Methods section. Duplicate flasks containing cells were incubated 6 h with buffer alone, or with cohydrolase (375 
p&ml), or with a carbohydrate, or with both, then assayed for cohydrolase content of the cells. Some of the values in this table are 
shown as individual results of duplicate analyses. The uptake values for cohydrolase are based on the average cohydrolase content of 
all the controls. M-6-P, mannose 6-phosphate; (Man),P, pentamannoside monophosphate; G-6-P. glucose 6-phosphate. 
Group Total protein CH concentration CH uptake 
(mg) (ng/mg protein) (W) 
Control 9.6, 9.9 1.73, 1.79 _ 
M-6-P alone (2 mM) 9.6, 9.9 1.62, 1.68 
Cohydrolase alone 10.5, 9.9 2.49, 2.38 49 
CH + M-6-P 10.2, 9.6 1.82, 1.82 7 
Control 8.85 
G-6-P (2 mM) 8.70 
(Man)sP 8.63 
Mannose (10 mM) 9.38 
Cohydrolase alone 9.08 
CH + G-6-P 8.70 
CH+(Man),P 8.33 
CH + mannose 8.33 
1.65, 1.69 _ 
1.62, 1.59 _ 
1.63, 1.60 _ 
1.56, 1.59 _ 
2.42, 2.39 48 
2.20, 2.13 32 
1.89, 1.86 14 
1.97, 1.89 17 
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TABLE IV 
INTERACTION BETWEEN COHYDROLASE AND GLUCOSIDASE 
Data are derived from two pooled dishes for each condition. Cohydrolase (125 pl, 60 pg/nl in buffer A) and glucosidase (275 PI, 1.8 
methylumbelliferyl-2-SD-glucopyranoside units/p1 in medium) were added to each flask, as shown below. The medium for control 
cells was supplemented with the corresponding volume of buffer or medium. The values in parantheses are the percent of added 
cohydrolase (CH) or enzyme taken up by the cells. 
Group Total Cohydrolase 
protein concentration 




+ enzyme 10.1 
Control 11.0 
+ CH + enzyme 12.2 








Glucosidase activity * (nmol/h) 




262 (24%) 475 
20 14 
258 (24%) 474 
23 11 
* Total activity. 
failure to observe a corresponding increased up- 
take of cohydrolase in the presence of both PS 
and glucosidase can be attributed to the use of a 
relatively large molar excess of the activator (i.e., 
the increased uptake of cohydrolase could not be 
measured accurately enough). 
Uptake of cerebroside glucosidase 
The above observation, that enzyme uptake was 
enhanced by cohydrolase in the presence of PS, 
was studied further. Control cells were incubated 
for 6 h without added enzyme, with PS alone (20 
pg/ml), or with cohydrolase alone (375 pg/ml), 
or with both. This yielded cells having unchanged 
enzyme specific activity (top four lines, Table VI). 
Incubation with exogenous glucosidase alone (14 
cerebroside units/ml) resulted in 24% of the added 
enzyme being taken up. As noted before, this 
represented a large increase above the endogenous 
level. Inclusion of PS with the enzyme produced a 
markedly higher uptake (37%). Inclusion of 
cohydrolase with the enzyme, without phospholi- 
TABLE V 
INTERACTION BETWEEN COHYDROLASE AND GLUCOSIDASE IN THE PRESENCE OF PHOSPHATIDYLSERINE 
Conditions as in Table IV, except that all flasks (except the last set) contained 20 /.&g/ml of PS. The values in parentheses are the 
percent of added cohydrolase (CH) or enzyme taken up by the cells. 











+ CH + enzyme 
No PS control 
* Total activity. 
6.8 1.44 38 15 
7.7 2.31 (45%) 41 29 
8.5 1.45 40 21 
7.4 1.45 349 (31%) 371 
7.1 1.51 37 49 
6.8 2.39 (40%) 515 (48%) 264 
6.6 1.38 34 18 
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TABLE VI 
UPTAKE OF GLUCOSYLCERAMIDE GLUCOSIDASE FROM CULTURE MEDIA AUGMENTED WITH COHYDROLASE 
AND PHOSP~ATI~YLSERIN~ 
The initial enzyme concentration was 14 cerebroside units per ml medium, the cohydrolase (CH) concentration was 375 pg/mI, and 










Total protein Glucosidase activity * (nmol/h) 
(4 in cells in medium 
10.4 74 45 
10.6 78 45 
10.2 78 39 
11.0 15 41 
10.6 209 287 
10.1 285 180 
10.9 235 278 
10.6 368 146 
Uptake of enzyme 






* Total activity. 
pid, had little effect on the enzyme uptake (28% 
uptake), as noted in Table IV. When all three 
components were added, a further enhancement 
was seen: 53% of the enzyme was taken up. 
An uptake experiment like the above was run 
with the use of methylumbeliiferyl-2-~-D-gluco- 
pyranoside in the enzyme assay system. The cells 
were incubated for 6 h with 17 methylumbel- 
life&2-B-D-glucopyranoside units of glucosidase 
per ml, Here the fractions of enzyme taken up 
under the four conditions were 21, 34 (+ PS), 25 
(+CH), and 53% (t PS + cohydrolase). The 
specific activity of the enzyme in the last set of 
cells was IO-times that in the untreated cells. The 
recovery of added enzyme in cells -t medium was 
62-72%, with and without activators, so one can- 
not attribute the increases in enzyme uptake to 
protection by PS or cohydrolase against enzyme 
inactivation. 
A time comparison of the enzyme uptake in the 
presence of PS, 3 vs. 6 h of incubation, showed 
that most of the uptake was complete within 3 h, 
with or without added cohydrolase: 28-30% up- 
take without the activator, 4550% with the 
activator. Doubling or tripling the cohydrolase 
concentration in the medium did not increase the 
enzyme uptake or recovery from the dishes. From 
this observation, it would appear that we used a 
large molar equivalent excess of cohydrolase, com- 
pared to the enzyme. The same conclusion was 
drawn before from the data of Table XV. 
In a test of carbohydrate interference, the up- 
take of glucosidase was studied as above, in the 
presence of 20 pg/ml of PS. This resulted in 
absorption of 31% of the added enzyme. The 
amount of uptake was unaffected by the presence 
of 1 mM mannose 6-phosphate or the pentaman- 
noside monophosphate (0.3 pg/ml). Evidently the 
enzyme-PS complex is not absorbed by neuro- 
blastoma cells via a mannosyl phosphate receptor. 
This is in agreement with the report that this 
enzyme is absorbed by human fibroblasts by a 
non-mannosyl phosphate mechanism 1191. 
When, in the same experiment, glucosidase up- 
take was enhanced by inclusion of both PS and 
cohydrokrse in the medium, the uptake of enzyme 
was 54% of the amount added and both mannose 
derivatives blocked the enhancement, bringing it 
back to 32 and 30%, respectively. It seems likely 
from these observations that part of the enzyme 
(31%) entered the cells by one mechanism and 
that the other portion (54-31 = 23%) entered the 
cells by forming a complex with cohydrolase (and 
PS) which entered by the same mechanism 
responsible for cohydrolase uptake. 
A comparison of different PS concentrations 
for their ability to enhance glucosidase uptake 
showed that the enhancement was maximal at PS 
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concentrations above 50 pg/ml in the medium 
(Fig. 2). Recoveries of enzyme in cells and media 
were 83-87%, so it is evident that the enhance- 
ment by PS was not the result of improved re- 
covery. 
Uptake of labeled phosphatidylserine 
When the medium contained only radioactive 
PS (10 pg/ml) for 6 h, less than 1% of the lipid 
was taken up by the cells. When 700 methylumbel- 
liferyl-2-B-D-gfucopyranoside units of enzyme were 
included in the 40 ml of medium, much more 
phospholipid was absorbed (9%). The uptake was 
proportional to the concentration of lipid, rising 
to as high as 35% of the added lipid (lower curve 
of Fig 3). 
When cohydrolase (375 pg/ml) was added to 
the medium together with glucosidase, the uptake 
of PS was enhanced even further (upper curve of 
Fig. 3). The recovery of added lipid in cells and 
medium was 78-91%, unaffected by the presence 
or absence of the two proteins. 
Uptake of glucosylceramide and its degradation 
An important question is whether the gluco- 
sidase taken up by the cells reached a subcellular 
Fig. 2. Dependence of glucocerebrosidase uptake (percent of 
enzyme added to flasks) on concentration of phosphati- 
dylserine in the medium. Two flasks containing 607 cerebro- 
side units were incubated for 6 h with differing concentrations 
of PS. The enzyme uptake was calculated from the activity in 
the cells and the activity added. The duplicate values are too 
close to distinguish except for the 30 and 80 pg points. The 
total cell protein in the two flasks at each time point was 
6.0-6.2 mg. 
PS CONC. [mg/ll 
Fig. 3. Dependence of phosphatidylserine uptake (cpm in cells 
from two flasks) on the concentration of PS in the medium and 
the presence or absence of cohydrolase. Each flask contained 
350 methylumbelliferyl-2-&@ucopyranoside units of gluco- 
sidase; half the flasks (upper curve) contained 375 pg/ml of 
cohydrolase. Note that the tick marks on the x axis are 4 units 
apart. 
location that is useful for the accelerated hydroly- 
sis of GlcCer. It was first necessary to produce a 
model version of Gaucher disease in the cells. This 
has been achieved readily in intact mice by injec- 
tion of a GlcCer glucosidase inactivator, conduri- 
to1 B epoxide [20,21], or an emulsion of GlcCer 
glucosidase in the nonionic detergent, Myrj 52 
[21]. The neuroblastoma cells were first examined 
with the detergent alone to make sure it was not 
highly toxic. A concentration of 0.1 mg/ml Myrj 
showed no visible signs of toxicity after 24 h, but 
0.3 mg/ml produced some floating dead cells and 
all cells were killed by 1 mg/ml Myrj. 
An emulsion was prepared with 25 pg GlcCer 
and 12.5 lug Myrj per ml of medium, and incubated 
with cells for 24 h. The cells were washed and the 
lipids were examined by TLC and charring. It was 
apparent that the cerebroside, normally not detec- 
table at the level examined, had become a major 
lipid component of the cells. Maintenance of 
washed cells in fresh medium for 2 or 5 days did 
not result in significant loss of cerebroside. A 
similar failure to hydrolyze exogenous labeled 
GlcCer by human cultured fibroblasts has been 
observed [22]. While the GlcCer concentration 
used in our experiment was higher than the 
observed 20 pg/ml limit for nontoxicity in macro- 
phage cultures [23], there was no sign of toxicity in 
our cells, as judged visually and by constancy of 
protein and DNA contents per culture (Table 
VII). 
To increase the sensitivity of the cells to exoge- 
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TABLE VII 
EVALUATION OF CELLS FOR PROTEIN AND DNA CONTENT AFTER TAKING UP GLUCOCEREBROSIDE AND 
PHOSPHATIDYLSERINE 
Cells in two flasks were incubated for 24 h with an emulsion of GlcCer (25 pg/ml) and Myrj 52, then washed and incubated further 
in serum-free medium. An additional set (lower part of table) was incubated with an emulsion of GlcCer/Myrj and PS (10 ng/ml). 







GlcCer/Myrj 0 17.5 148 8.4 
2 18.0 150 8.3 
5 16.7 153 9.1 
GlcCer/Myrj + PS 0 16.6 148 8.9 
2 17.1 152 8.9 
5 16.5 150 9.1 
Control cells (no lipid) 15.8 149 9.4 
nous materials, we repeated the experiment with 
lower concentrations of GlcCer (5 pg/ml). The 
resultant GlcCer spot on the TLC plate was fainter 
than before, but nevertheless quite distinct. At this 
level too there was little or no detectable disap- 
pearance of the glycolipid over a j-day period. 
Phosphatidylserine (5 pg/ml), added with the 
GlcCer, was also absorbed but the elevation in 
cellular PS level was found to disappear after 2 
days. The PS was clearly effective in speeding the 
disappearance of GlcCer. Our observations are 
consistent with the report that an emulsion of 
GlcCer with PS, injected intravenously into rats, 
resulted in uptake of the cerebroside by liver and 
spleen and its subsequent rapid disappearance [24]. 
The ability of exogenous glucosidase, cohydro- 
lase, and PS to speed the disappearance of GlcCer 
from the model Gaucher cells was tested under the 
same conditions. Cells were loaded with cerebro- 
side by a 24-h incubation with emulsified GlcCer, 
5 pg/ml. TLC of the lipids (Fig. 4) showed again 
that a distinct amount of cerebroside had entered 
the cells (lane B vs. control cells, lane A) and that 
most of the cerebroside was still present after 24 h 
of exposure to stock medium (lane C vs. B). Cells 
which were exposed to glucosidase (550 cerebro- 
side units) for 24 h showed a distinct decrease in 
cerebroside content (D vs. C). Exposure to PS 
alone, 5 pg/ml, produced an even more effective 
disappearance of the lipid (E vs. D) and the 
combination of enzyme and PS was more effective 
than either alone (F vs. D or E). Glucosidase with 
cohydrolase (375 pg/ml) was not more effective 
than glucosidase alone (G vs. D), an observation 
to be expected from the previous data. The stron- 
A B C D E F G t-l I J 
Fig. 4. Thin-layer plate showing neuroblastoma lipids, devel- 
oped with chloroform/methanol/aqueous KC1 in ammonium 
hydroxide. The highest spot is due to GlcCer. Each lane was 
derived from 1/30th of the lipids extracted from two flasks of 
cells. Lane A is from cells treated only with stock medium; 
lanes B-H are from cells which had been loaded with gluco- 
cerebroside for 24 h, then washed with fresh medium and 
treated for another 24 h with various media. Lane B: cells 
extracted immediately after washing, showing the accumulated 
glucolipid. Lane C: cells exposed only to stock medium for 24 
h, showing only slight disappearance of glucolipid. Lane D: 
exposed 24 h to medium augmented with glucosidase. E: 
exposed 24 h to PS medium. F: exposed to glucosidase + PS. 
G: glucosidase+cohydrolase. H: exposed to all three, gluco- 
sidase + PS + cohydrolase. Standards in lane I: three families of 
galactosylceramide at the top, sulfatide at the center, 
sphingomyelin near the bottom Lane J: phosphatidylserine, a 
little faster moving than sphingomyelin on this plate. The 
darkest spot in the cell lipids is phosphatidylethanolamine and 
the next darkest is phosphatidylcholine. 
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gest effect was produced by a mixture of the three, 
enzyme + cohydrolase + phospholipid, which pro- 
duced almost complete disappearance of the stored 
glucolipid (lane H). 
In a similar experiment, the effect of PS plus 
cohydrolase (without added enzyme) was tested. 
The presence of labeled PS during the second 24 h 
incubation period (9500 cpm in each pair of cul- 
ture dishes) was found to stimulate the disap- 
pearance of the glycolipid, as noted before. The 
presence of cohydrolase alone had little or no 
effect on the amount of GlcCer remaining in the 
cells, and cohydrolase did not enhance the effect 
of PS. 
The amounts of radioactivity found in the cells 
were 879 and 723 cpm (about 8%) with and 
without added cohydrolase, respectively. Only a 
very small proportion of the absorbed labeled 
serine in the phospholipid was found in other cell 
components after the 24-h period. This makes it 
unlikely that the effect of PS was due to conver- 
sion to other substances. 
A repetition of the experiment shown in Fig. 4 
was made with labeled GlcCer to place the 
observations on a more precise basis and to prove 
that the stimulation of GlcCer disappearance was 
TABLE VIII 
DISAPPEARANCE OF STORED GLUCOCEREBROSIDE 
FROM NEUROBLASTOMA CELLS 
Two dishes of cells were preloaded with GlcCer (100 cpm/gg) 
for 24 h, washed with fresh medium, then incubated for 24 h 
with medium containing one or more additions. The lipids in 
the cells were extracted and the GlcCer was isolated by silica 
gel chromatography. The decrease in cellular GlcCer was 
calculated by comparison with the radioactivity of GlcCer in 
cells that were not incubated for the second 24 h period. CH, 
cohydrolase. 
Addition GlcCer decrease 





Glucosidase + PS 52 
Glucosidase + CH 27 
Cohydrolase + PS 24 
Glucosidase + PS + CH 14 
due to hydrolysis rather than enhanced addition 
of sugar moieties. The control cells (Table VIII) 
took up 93 out of 200 pg of GlcCer added. 
Cohydrolase produced a small but measurable 
stimulation of GlcCer disappearance, which had 
not been detected in the previous visual estimation 
experiments. Otherwise, the results were much like 
those observed in Fig. 4. An important finding 
was that the polar lipids, eluted from the silica gel 
columns with chloroform/methanol/water 10 : 
10 : 1, contained only a very small amount of 
radioactivity (3% or less). Moreover, the ganglio- 
side fraction, obtained by partitioning the total 
lipids between chloroform, methanol, and water 
[25], also contained very little activity (3% or less). 
These observations show that the decreased activ- 
ity in the cells treated with CH + PS + glucosidase 
was not the result of enhanced synthetic activity 
(to form oligosaccharide cerarnides). 
Discussion 
Our observations are consistent with previously 
published evidence indicating that glucosidase 
forms a complex with PS [4-71. We found, by 
enzyme assay and radioactivity monitoring (Table 
VI and Figs. 2 and 3), that each of these sub- 
stances enhanced the uptake of the other. The 
complex of the two substances, once they were 
absorbed by the cells, was effective in stimulating 
the hydrolysis of previously absorbed GlcCer (Ta- 
ble VIII and Fig. 4). Phosphatidylserine alone also 
stimulated GlcCer hydrolysis, evidently inter- 
acting within the cells with the endogenous gluco- 
sidase, which was not in a fully activated state. 
Cultured fibroblasts and lymphocytes from some 
Gaucher patients have also been shown to re- 
spond similarly to PS added in vitro [26,27]. It 
may be noted that our assay for glucosidase in 
vitro (Table VI, line 6) did not show the stimu- 
lation effect, apparently because the absorbed PS 
- 0.8 pg in the assay system - dissociated by 
dilution in the assay procedure. 
That cohydrolase and PS do not interact with 
one another was indicated by the failure of either 
substance to enhance the uptake of the other. This 
too agrees with previous work [5,6], which showed 
that cohydrolase had little stimulatory effect on 
glucosidase in vitro unless an acidic lipid was 
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present. However, cohydrolase did enhance PS 
uptake by the cells when the latter was bound to 
glucosidase. From Table VIII, lines 1 and 4, it 
would appear that the endogenous glucosidase in 
the neuroblastoma cells was almost fully saturated 
with cohydrolase. 
The mechanism of glucosidase uptake remains 
obscure and we know only that PS and PS + 
cohydrolase improve its absorption. Perhaps the 
enzyme, without added acidic lipid, binds to acidic 
lipids in the plasma membrane and the complex is 
then incorporated into a type of lysosome. The 
complex of enzyme and lipid, presented to the 
cells exogenously, may contain the enzyme as part 
of a micellar structure dominated by the lipid. 
This micelle may enter the cells by permeating the 
plasma membrane. Cohydrolase, on the other 
hand, seems to be absorbed by a sugar-sensitive 
receptor region (Table III). The ternary complex 
formed between cohydrolase, PS and glucosidase 
appears to be absorbed by this mechanism, since 
its uptake could be blocked by mannose phos- 
phate and pentamannosyl phosphate despite the 
possible presence of micellar PS. The pentasac- 
charide has been found to strongly inhibit 
glucuronidase uptake, apparently through its com- 
petition for mannosyl phosphate receptors [lo]. 
We found by direct measurement that PS and 
cohydrolase together improved the ability of cells 
to take up GlcCer glucosidase and, importantly, 
that the enzyme taken up in this manner was in a 
cellular location that allowed it to act on its stored 
substrate. This observation may be of value in the 
treatment of Gaucher disease. Administration of 
the ternary complex would utilize chemically un- 
modified enzyme and therefore may be safer than 
the chemical derivatization approach, in which the 
enzyme is attached chemically to an oligosac- 
charide or glycoprotein and might thus produce 
immune reactions. 
The injection of Gaucher patients with highly 
purified glucosidase has not yet proved to be 
effective enough to reverse the symptoms [28,29]. 
One could hypothesize that there is already a great 
surplus of cohydrolase in these patients and that 
the injected enzyme ought to reach the cohydro- 
lase and become activated. Apparently this does 
not happen. One possible explanation is that the 
amount of available acidic phospholipid, which is 
needed for forming the active ternary complex, is 
inadequate. It is possible, therefore, that gluco- 
sidase should first be combined with PS before 
injection. 
Experiments with mice, in which the level of 
liver GlcCer rose as the result of injecting emulsi- 
fied GlcCer or a glucosidase inactivator, showed 
that the animals responded with a rapid increase 
in the level of liver cohydrolase [21]. This re- 
sponse, which mimicked that of Gaucher patients, 
suggests that the activator protein is elevated by 
the cells in order to stimulate the endogenous 
glucosidase and normalize the GlcCer level. In 
view of the known role of acidic phospholipids in 
activating the glucosidase, and our uptake find- 
ings, it is possible that the cellular level of PS is 
another important controlling factor. 
Phosphatidylserine may also play a specific role 
in cellular uptake mechanisms. It has been shown 
that red cells coated with this lipid are taken up 
by the reticuloendothelial system much more ef- 
fectively [30]. It also aids the uptake of sterols 
when mixed with sterol carrier protein [31,32], the 
uptake of y-aminobutyric acid by synaptosomes 
[33], and the uptake of galactosylceramide and 
lactosylceramide by cultured fibroblasts [34]. In 
this last study, the acidic lipid was found to accel- 
erate the hydrolysis of the glycolipids, a finding 
like ours. 
Since cells and intact animals [21] readily ab- 
sorb GlcCer, when emulsified with Myrj 52, it 
becomes possible to induce a model form of 
Gaucher disease in vitro and in vivo. This may 
ease the problem of testing chemotherapeutic 
treatments for the disorder. While the cell type 
used in the present study is derived from brain, 
the symptoms of Gaucher disease are derived 
primarily from reticuloendothelial cells, which 
could be studied by this approach. 
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